SynthesisFrontiers in immunology2024

Durvalumab and pembrolizumab in advanced biliary tract cancer: a reconstructed patient-level mimic head-to-head comparative analysis.

Bi-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.